New Zealand: A budding industry for cannabis products in New Zealand

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

New Zealand: A budding industry for cannabis products in New Zealand

Sponsored by

aj-park.png
Green background of leaves. Young cannabis plant. Cannabis at the beginning of flowering. Northern light strain. Medicinal indica with CBD. In door grow hemp. moody color

In September 2020, New Zealanders will participate in a non-binding cannabis referendum on the question of whether to legalise the use and supply of cannabis. New Zealanders will be given the option of voting either for or against the proposed Cannabis Legalisation and Control Bill (the Bill). The final version of the Bill, which was released in May 2020, legalises the use of cannabis for persons over the age of 20, but places severe restrictions around the promotion and packaging of cannabis products.


Medicinal cannabis

In New Zealand, the use of cannabis for medicinal purposes is legal, and licensed commercial cultivation and manufacture of medicinal cannabis is permitted.

Trademarks covering medicinal cannabis can be registered with the Intellectual Property Office of New Zealand (IPONZ), provided the specifications are restricted to Class 5 (pharmaceutical products). If the trademark contains elements indicating that the goods are medicinal cannabis, but covers goods in other classes, IPONZ will raise a Section 17(1)(a) Trade Marks Act 2002 (TMA) "likely to cause confusion" objection against the application.

Acceptable descriptions in Class 5 would include "medicinal cannabis oil; medicinal cannabis balm; medicinal cannabis cookies." Trademark owners should take note of this policy, and cover all relevant medicinal cannabis products in Class 5, regardless of whether these products are in capsule, oil, or edible form.


Recreational cannabis

In New Zealand, the Misuse of Drugs Act 1975 prohibits the use and supply of recreational cannabis.

Trademarks covering recreational cannabis can nevertheless be registered with IPONZ. Article (15)4 of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which New Zealand has ratified, provides that "the nature of the goods or services to which a trade mark is to be applied shall in no case form an obstacle to registration of the trade mark."

Consequently, IPONZ should not raise a Section 17(1)(b) TMA "contrary to law" objection to a trademark application covering recreational cannabis, and the application should proceed to registration if there are no other issues.

Trademark owners should note, however, that if a trademark is not used for a continuous three-year period, it may become vulnerable to revocation for non-use. Although a trademark owner in New Zealand can successfully defend a non-use action by showing "special circumstances that are outside the control of the owner" under Section 66(2) of the TMA, it is unlikely that the prohibition against the use and supply of recreational cannabis will qualify as "special circumstances."

Those who register trademarks for recreational cannabis before the Bill passes are therefore at risk of having their registrations revoked for non-use.


The proposed Cannabis Legalisation and Control Bill

As part of its harm prevention approach, the proposed Bill places severe restrictions on the promotion of recreational cannabis products and imposes strict packaging standards.

The Bill also places limitations on the use of cannabis product trademarks. In particular, the Bill prohibits cannabis product trademarks from being:


  • promoted or advertised;

  • displayed outside a retailer's place of business;

  • used on non-cannabis products; or

  • used in relation to services, activities, events, scholarships and sponsorships.

In addition, the Bill gives the governor-general the power to make regulations prescribing the appearance of packaging for cannabis products, including the font, size, and colour scheme of cannabis product trademarks. These regulations are likely to be similar to the Smoke-Free Environment Regulations, which prescribe a standard font and size for tobacco product trademarks.


Key takeaways

If there is a majority yes vote in New Zealand's upcoming cannabis referendum, and the proposed Bill passes, New Zealand's trademark landscape will change.

Trademark applicants looking to register and use cannabis product trademarks in New Zealand should note that the font, size and colour of their trademarks are likely to be governed by strict regulations, and that they will be prohibited from advertising and promoting their trademarks in the New Zealand market.

more from across site and SHARED ros bottom lb

More from across our site

Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
UKIPO will remain a competitive option as long as efficient service continues
A future opt-out has not been ruled out, but practitioners warn that the UK could fall behind in the AI race
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
Mike Rueckheim reunites with 12 of his former Winston & Strawn colleagues as King & Spalding continues aggressive hiring streak
As global commerce continues to expand through e-commerce platforms and digital marketplaces, protecting brands has become a growing challenge for organisations worldwide. Counterfeiting, intellectual property infringement, and online brand abuse are increasing across industries, making brand protection strategies a critical priority for businesses.
Henrik Holzapfel and Chuck Larsen of McDermott Will & Schulte explain why a Court of Appeal ruling could promote access to justice and present a growth opportunity for litigation finance
A co-partner in charge says the UK prosecution teams are a ‘vital’ part of the firm’s offering, while praising a key injunction win
Gift this article